Author:
Pescovitz Md,Conti D,Dunn J,Gonwa T,Halloran P,Sollinger H,Tomlanovich S,Weinstein S,Inokuchi S,Kiberd B,Kittur D,Merion Rm,Norman D,Shoker A,Wilburn R,Nicholls Aj,Arterburn S,Dumont E
Reference12 articles.
1. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients;Sollinger HW, for The US Renal Transplant Mycophenolate Mofetil Study Group;Transplantation,1995
2. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation;The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group;Transplantation,1996
3. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients;Kobashigawa;Transplantation,1998
4. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation;Mathew TH, for the Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group;Transplantation,1998
5. Bioavailability improvement of mycophenolic acid through amino ester derivatization;Lee;Pharm Res,1990
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献